ReviewFrontiers in oncology2019

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders.

James P Dugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.